Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)

SHA:600664 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,268	10,401	8,445	7,599	8,940	7,997
Market Cap Growth	23.93%	23.17%	11.14%	-15.00%	11.79%	-15.83%
Enterprise Value	8,566	9,834	8,373	8,608	10,444	8,672
Last Close Price	3.68	4.13	3.35	3.01	3.55	3.19
PE Ratio	14.11	16.54	21.37	16.34	24.09	-
Forward PE	-	14.91	14.91	14.91	14.91	14.91
PS Ratio	0.57	0.64	0.55	0.55	0.70	0.74
PB Ratio	1.47	1.71	1.56	1.54	2.02	2.01
P/TBV Ratio	1.81	2.12	2.00	1.98	2.69	2.68
P/FCF Ratio	18.81	15.04	9.78	14.27	-	-
P/OCF Ratio	15.48	13.13	8.89	12.22	-	-
EV/Sales Ratio	0.53	0.61	0.54	0.62	0.82	0.80
EV/EBITDA Ratio	6.74	8.09	9.65	10.48	14.57	-
EV/EBIT Ratio	8.48	10.09	13.50	15.43	23.33	-
EV/FCF Ratio	17.38	14.22	9.70	16.17	-	-
Debt / Equity Ratio	0.22	0.29	0.34	0.44	0.52	0.45
Debt / EBITDA Ratio	1.07	1.43	2.04	2.48	3.06	-
Debt / FCF Ratio	2.75	2.56	2.15	4.04	-	-
Asset Turnover	1.15	1.13	1.12	1.05	1.04	0.89
Inventory Turnover	6.28	6.09	6.14	5.40	5.01	4.39
Quick Ratio	1.14	1.08	0.99	0.93	0.82	0.77
Current Ratio	1.42	1.36	1.26	1.20	1.11	1.07
Return on Equity (ROE)	12.06%	12.00%	9.15%	10.94%	9.75%	-21.05%
Return on Assets (ROA)	4.47%	4.24%	2.81%	2.65%	2.27%	-4.12%
Return on Capital (ROIC)	8.27%	8.05%	5.39%	5.04%	4.48%	-8.11%
Return on Capital Employed (ROCE)	15.00%	15.00%	10.60%	10.30%	9.00%	-
Earnings Yield	7.18%	6.05%	4.68%	6.12%	4.15%	-13.48%
FCF Yield	5.32%	6.65%	10.22%	7.01%	-2.67%	-10.58%
Payout Ratio	7.73%	7.49%	11.17%	11.68%	16.59%	-
Buyback Yield / Dilution	-2.39%	-1.82%	4.40%	-4.46%	1.29%	10.19%
Total Shareholder Return	-2.39%	-1.82%	4.40%	-4.46%	1.29%	10.19%

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.